Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

November 27, 2027

Conditions

Parkinsons Disease (PD)

Interventions

DRUG

Gamma- glutamylcysteine

400 mg (two times) per day

Trial Locations (1)

UPMC Presbyterian Hospital, Pittsburgh

All Listed Sponsors

collaborator

Waste Connections Inc

UNKNOWN

lead

Pravat Mandal

OTHER